Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder

Autor: Richard J. Zeifman, Hannes Kettner, Stephen Ross, Brandon Weiss, Michael C. Mithoefer, Ann T. Mithoefer, Anne C. Wagner

Publikováno v: European Journal of Psychotraumatology, Vol 15, Iss 1 (2024)

ABSTRACTBackground: MDMA-assisted psychotherapy (MDMA-AP) is a combined psychotherapeutic and pharmacologic intervention that shows promise in the treatment of posttraumatic stress disorder (PTSD). Although therapeutic alliance has been established a

Externí odkaz: https://doaj.org/article/f853b5bb466445abb185e07d3059d070

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

Autor: Candice M. Monson, Anne C. Wagner, Ann T. Mithoefer, Rachel E. Liebman, Allison A. Feduccia, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin, Michael C. Mithoefer

Publikováno v: European Journal of Psychotraumatology, Vol 11, Iss 1 (2020)

Cognitive-behavioural conjoint therapy (CBCT) for PTSD has been shown to improve PTSD, relationship adjustment, and the health and well-being of partners. MDMA (3,4-methylenedioxymethamphetamine) has been used to facilitate an individual therapy for

Externí odkaz: https://doaj.org/article/7d5273a4156f4c4db10f2e5e9ba3044b

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

Autor: Ann T Mithoefer, Candice M. Monson, Lisa Jerome, Michael C. Mithoefer, Berra Yazar-Klosinski, Amy Emerson, Anne C. Wagner, Rachel E. Liebman, Rick Doblin, Allison A. Feduccia

Publikováno v: European Journal of Psychotraumatology, Vol 11, Iss 1 (2020)
European Journal of Psychotraumatology
article-version (VoR) Version of Record

Cognitive-behavioural conjoint therapy (CBCT) for PTSD has been shown to improve PTSD, relationship adjustment, and the health and well-being of partners. MDMA (3,4-methylenedioxymethamphetamine) has been used to facilitate an individual therapy for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c743d73b595d30313654853e919ab062
https://doi.org/10.1080/20008198.2020.1840123

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

Autor: Ann T Mithoefer, Rick Doblin, Allison A. Feduccia, Michael C. Mithoefer, Julie Holland, Joy H. Wymer, Scott Hamilton, Lisa Jerome, Mark Wagner, Amy Emerson, Berra Yazar-Klosinski

Publikováno v: The lancet. Psychiatry. 5(6)

Post-traumatic stress disorder (PTSD) is prevalent in military personnel and first responders, many of whom do not respond to currently available treatments. This study aimed to assess the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80861fa926b0d5eab8c3375798e7595
https://pubmed.ncbi.nlm.nih.gov/29728331

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

Autor: Yvonne Michel, Timothy D. Brewerton, Lisa Jerome, Mark T. Wagner, Ann T Mithoefer, Rick Doblin, Berra Yazar-Klosinski, Michael C. Mithoefer, Scott F Martin

Publikováno v: Journal of Psychopharmacology (Oxford, England)

We report follow-up data evaluating the long-term outcomes for the first completed trial of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for chronic, treatment-resistant post-traumatic stress disorder (PTSD) (Mithoefer et al., 2011

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8aa74f95e9009fc0f00b48a511d5c24
http://europepmc.org/articles/PMC3573678